e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Exercise tolerance and its determinants across pathologies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The incremental shuttle walk test in pulmonary hypertension
Ö. Ertan (Kirklareli, Turkey), G. Kuran Aslan (Istanbul, Turkey), B. Akinci (Istanbul, Turkey), E. Develi (Istanbul, Turkey), N. Okumus (Istanbul, Turkey)
Source:
International Congress 2019 – Exercise tolerance and its determinants across pathologies
Session:
Exercise tolerance and its determinants across pathologies
Session type:
Thematic Poster
Number:
1198
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ö. Ertan (Kirklareli, Turkey), G. Kuran Aslan (Istanbul, Turkey), B. Akinci (Istanbul, Turkey), E. Develi (Istanbul, Turkey), N. Okumus (Istanbul, Turkey). The incremental shuttle walk test in pulmonary hypertension. 1198
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Repeatability of incremental shuttle and 6 minute walk test in pulmonary hypertension
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009
The incremental shuttle walking test safely assesses exercise capacity in pulmonary hypertension
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004
Percent-predicted incremental shuttle walking test distance stratifies risk in pulmonary arterial hypertension
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020
Effects of sildenafil on incremental shuttle walking test and haemodynamics in patients with pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 370s
Year: 2002
Incremental shuttle walking test distance predicts poor prognosis in pulmonary hypertension
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004
Using the six-minute walk test to assess exercise capacity in people with pulmonary hypertension
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012
Comparison of the six minute walking test, the shuttle test and the cardiopulmonary exercise test in the evaluation of patients with established PAH
Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension
Year: 2005
Physiological response to the six-minute walk test in pulmonary arterial hypertension
Source: Eur Respir J 2005; 26: 667-672
Year: 2005
Relationship between sit-to-stand test and six-minute walk test in patients with pulmonary arterial hypertension
Source: International Congress 2015 – The challenge of choosing the best physical and functional assessment methods
Year: 2015
Comparability of shuttle walk test with 6-minutes walk test in pulmonary diseases with emphasis on pulmonary arterial hypertension
Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases
Year: 2013
Six minute treadmill test as a new endpoint in pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009
Comparative assessment of the incremental shuttle walk and incremental cycle ergometry tests in patients with idiopathic pulmonary fibrosis.
Source: Virtual Congress 2020 – Advances in lung function practice
Year: 2020
A comparison of exercise capacity results from cardiopulmonary exercise test, shuttle walk and treadmill tests after pulmonary rehabilitation
Source: Annual Congress 2007 - Assessment and outcomes in patients with chronic airway obstruction
Year: 2007
Comparison of 6-minute walk test and shuttle walk test in patients with interstitial lung diseases
Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing
Year: 2010
The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension
Source: Eur Respir J 2010; 36: 1294-1301
Year: 2010
Spiroveloergometry and 6-minute walking test for exercise capacity assessment in patients with primary pulmonary hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 16s
Year: 2005
Incremental shuttle walking test distance is reduced in patients with pulmonary hypertension in WHO Functional Class I
Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise
Year: 2018
Dynamic hyperinflation during the 6-minute walk test and incremental cycling exercise in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 121s
Year: 2004
Comparison of endurance shuttle walk test and cycle endurance test in pulmonary rehabilitation program
Source: International Congress 2019 – Novel interventions and models of pulmonary rehabilitation
Year: 2019
Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension
Source: Eur Respir J 2012; 40: 1410-1419
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept